vs

Side-by-side financial comparison of CORVEL CORP (CRVL) and MARSH & MCLENNAN COMPANIES, INC. (MRSH). Click either name above to swap in a different company.

MARSH & MCLENNAN COMPANIES, INC. is the larger business by last-quarter revenue ($6.6B vs $235.6M, roughly 28.0× CORVEL CORP). MARSH & MCLENNAN COMPANIES, INC. runs the higher net margin — 12.4% vs 10.3%, a 2.2% gap on every dollar of revenue. On growth, MARSH & MCLENNAN COMPANIES, INC. posted the faster year-over-year revenue change (8.7% vs 3.4%). MARSH & MCLENNAN COMPANIES, INC. produced more free cash flow last quarter ($2.1B vs $35.2M). Over the past eight quarters, CORVEL CORP's revenue compounded faster (6.6% CAGR vs 0.9%).

Corvel Corp is a U.S.-headquartered provider of integrated workers’ compensation, healthcare management, and risk mitigation solutions. It serves insurance carriers, self-insured employers, and public sector clients, delivering services to control healthcare costs, improve care outcomes, and optimize administrative operations.

Marsh & McLennan Companies, Inc., doing business as Marsh McLennan and Marsh, is a global professional services firm, headquartered in New York City with businesses in insurance brokerage, risk management, reinsurance services, talent management, investment advisory, and management consulting. Its four main operating companies are Marsh, which offers risk management, insurance broking, insurance program management, risk consulting, analytical modeling and alternative risk financing services; ...

CRVL vs MRSH — Head-to-Head

Bigger by revenue
MRSH
MRSH
28.0× larger
MRSH
$6.6B
$235.6M
CRVL
Growing faster (revenue YoY)
MRSH
MRSH
+5.3% gap
MRSH
8.7%
3.4%
CRVL
Higher net margin
MRSH
MRSH
2.2% more per $
MRSH
12.4%
10.3%
CRVL
More free cash flow
MRSH
MRSH
$2.0B more FCF
MRSH
$2.1B
$35.2M
CRVL
Faster 2-yr revenue CAGR
CRVL
CRVL
Annualised
CRVL
6.6%
0.9%
MRSH

Income Statement — Q4 2025 vs Q4 2025

Metric
CRVL
CRVL
MRSH
MRSH
Revenue
$235.6M
$6.6B
Net Profit
$24.2M
$821.0M
Gross Margin
23.3%
Operating Margin
13.7%
18.5%
Net Margin
10.3%
12.4%
Revenue YoY
3.4%
8.7%
Net Profit YoY
1.7%
4.2%
EPS (diluted)
$0.47
$1.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRVL
CRVL
MRSH
MRSH
Q4 25
$235.6M
$6.6B
Q3 25
$239.6M
$6.4B
Q2 25
$234.7M
$7.0B
Q1 25
$231.5M
$7.1B
Q4 24
$228.0M
$6.1B
Q3 24
$224.4M
$5.7B
Q2 24
$211.7M
$6.2B
Q1 24
$207.2M
$6.5B
Net Profit
CRVL
CRVL
MRSH
MRSH
Q4 25
$24.2M
$821.0M
Q3 25
$27.9M
$747.0M
Q2 25
$27.2M
$1.2B
Q1 25
$26.4M
$1.4B
Q4 24
$23.8M
$788.0M
Q3 24
$23.4M
$747.0M
Q2 24
$21.6M
$1.1B
Q1 24
$19.5M
$1.4B
Gross Margin
CRVL
CRVL
MRSH
MRSH
Q4 25
23.3%
Q3 25
24.3%
Q2 25
24.2%
Q1 25
25.0%
Q4 24
23.2%
Q3 24
22.6%
Q2 24
22.7%
Q1 24
20.9%
Operating Margin
CRVL
CRVL
MRSH
MRSH
Q4 25
13.7%
18.5%
Q3 25
15.0%
18.4%
Q2 25
15.0%
26.2%
Q1 25
14.4%
28.4%
Q4 24
13.5%
18.8%
Q3 24
12.8%
19.4%
Q2 24
13.2%
26.4%
Q1 24
10.9%
29.7%
Net Margin
CRVL
CRVL
MRSH
MRSH
Q4 25
10.3%
12.4%
Q3 25
11.6%
11.8%
Q2 25
11.6%
17.4%
Q1 25
11.4%
19.6%
Q4 24
10.4%
13.0%
Q3 24
10.4%
13.1%
Q2 24
10.2%
18.1%
Q1 24
9.4%
21.6%
EPS (diluted)
CRVL
CRVL
MRSH
MRSH
Q4 25
$0.47
$1.68
Q3 25
$0.54
$1.51
Q2 25
$0.52
$2.45
Q1 25
$-1.23
$2.79
Q4 24
$0.46
$1.58
Q3 24
$1.35
$1.51
Q2 24
$1.25
$2.27
Q1 24
$1.12
$2.82

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRVL
CRVL
MRSH
MRSH
Cash + ST InvestmentsLiquidity on hand
$230.0M
$2.7B
Total DebtLower is stronger
$19.6B
Stockholders' EquityBook value
$375.7M
$15.3B
Total Assets
$644.8M
$58.7B
Debt / EquityLower = less leverage
1.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRVL
CRVL
MRSH
MRSH
Q4 25
$230.0M
$2.7B
Q3 25
$207.5M
$2.5B
Q2 25
$202.0M
$1.7B
Q1 25
$170.6M
$1.6B
Q4 24
$162.9M
$2.4B
Q3 24
$138.3M
$1.8B
Q2 24
$131.9M
$1.7B
Q1 24
$105.6M
$1.5B
Total Debt
CRVL
CRVL
MRSH
MRSH
Q4 25
$19.6B
Q3 25
$19.6B
Q2 25
$19.6B
Q1 25
$19.5B
Q4 24
$19.9B
Q3 24
$12.8B
Q2 24
$12.8B
Q1 24
$13.4B
Stockholders' Equity
CRVL
CRVL
MRSH
MRSH
Q4 25
$375.7M
$15.3B
Q3 25
$362.8M
$15.4B
Q2 25
$342.5M
$16.0B
Q1 25
$322.0M
$14.3B
Q4 24
$300.9M
$13.5B
Q3 24
$282.8M
$13.9B
Q2 24
$263.9M
$13.6B
Q1 24
$247.6M
$12.6B
Total Assets
CRVL
CRVL
MRSH
MRSH
Q4 25
$644.8M
$58.7B
Q3 25
$611.7M
$58.8B
Q2 25
$597.4M
$58.6B
Q1 25
$546.0M
$57.0B
Q4 24
$538.8M
$56.5B
Q3 24
$518.6M
$49.9B
Q2 24
$486.2M
$48.6B
Q1 24
$454.7M
$47.6B
Debt / Equity
CRVL
CRVL
MRSH
MRSH
Q4 25
1.28×
Q3 25
1.27×
Q2 25
1.23×
Q1 25
1.37×
Q4 24
1.47×
Q3 24
0.93×
Q2 24
0.94×
Q1 24
1.06×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRVL
CRVL
MRSH
MRSH
Operating Cash FlowLast quarter
$46.1M
$2.2B
Free Cash FlowOCF − Capex
$35.2M
$2.1B
FCF MarginFCF / Revenue
14.9%
31.2%
Capex IntensityCapex / Revenue
4.7%
1.6%
Cash ConversionOCF / Net Profit
1.91×
2.63×
TTM Free Cash FlowTrailing 4 quarters
$104.3M
$5.0B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRVL
CRVL
MRSH
MRSH
Q4 25
$46.1M
$2.2B
Q3 25
$25.0M
$2.1B
Q2 25
$55.0M
$1.7B
Q1 25
$22.9M
$-622.0M
Q4 24
$41.6M
$2.0B
Q3 24
$22.3M
$1.9B
Q2 24
$40.4M
$1.2B
Q1 24
$15.2M
$-781.0M
Free Cash Flow
CRVL
CRVL
MRSH
MRSH
Q4 25
$35.2M
$2.1B
Q3 25
$15.3M
$2.0B
Q2 25
$39.5M
$1.6B
Q1 25
$14.3M
$-677.0M
Q4 24
$32.1M
$1.9B
Q3 24
$12.4M
$1.8B
Q2 24
$32.8M
$1.1B
Q1 24
$5.2M
$-868.0M
FCF Margin
CRVL
CRVL
MRSH
MRSH
Q4 25
14.9%
31.2%
Q3 25
6.4%
31.6%
Q2 25
16.8%
23.1%
Q1 25
6.2%
-9.6%
Q4 24
14.1%
31.0%
Q3 24
5.5%
32.3%
Q2 24
15.5%
18.2%
Q1 24
2.5%
-13.4%
Capex Intensity
CRVL
CRVL
MRSH
MRSH
Q4 25
4.7%
1.6%
Q3 25
4.1%
1.1%
Q2 25
6.6%
0.8%
Q1 25
3.7%
0.8%
Q4 24
4.2%
1.3%
Q3 24
4.4%
1.3%
Q2 24
3.6%
1.3%
Q1 24
4.8%
1.3%
Cash Conversion
CRVL
CRVL
MRSH
MRSH
Q4 25
1.91×
2.63×
Q3 25
0.90×
2.79×
Q2 25
2.02×
1.38×
Q1 25
0.87×
-0.45×
Q4 24
1.75×
2.48×
Q3 24
0.95×
2.56×
Q2 24
1.87×
1.08×
Q1 24
0.78×
-0.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CRVL
CRVL

Patient Management Services$146.1M62%
Network Solutions Services$89.6M38%

MRSH
MRSH

Marsh Insurance Group$3.6B55%
Consulting Segment$2.6B40%
Guy Carpenter Reinsurance Group$179.0M3%
Other$175.0M3%

Related Comparisons